Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in JNJ — Johnson & Johnson

CIK 1164508 BOSTON, MA

Position in JNJ

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$245,586,179
-$273,636,056 QoQ
Shares Held
1,004,689
-60.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 69.19574116965549.ToString("F0")% Shared 0.ToString("F0")% None 30.804258830344516.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,760,772,587 across 11 Drug Manufacturers - General names. JNJ ranks #6 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 JNJ
Johnson & Johnson
This page
1,004,689 $245,586,179

All Filings in JNJ

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $245,586,179 1,004,689
2025-12-31 $519,222,235 2,508,926
2025-09-30 $429,149,027 2,314,470
2025-06-30 $375,636,384 2,459,158
2025-03-31 $547,496,879 3,301,356
2024-12-31 $342,266,369 2,366,660
2024-09-30 $186,831,843 1,152,856
2024-06-30 $121,037,434 828,116
2024-03-31 $111,786,545 706,660
2023-09-30 $6,471,879 41,553
2023-03-31 $188,257,265 1,214,563
2022-12-31 $140,561,111 795,704
2022-09-30 $15,152,456 92,755
2022-06-30 $5,299,383 29,854
2022-03-31 $1,179,219,300 6,653,610
2021-12-31 $829,343,596 4,847,978
2021-09-30 $856,659,308 5,304,392
2021-06-30 $1,141,445,075 6,928,767
2021-03-31 $1,479,970,763 9,004,994
2020-12-31 $994,017,903 6,316,037
2020-09-30 $1,151,478,713 7,734,274
2020-06-30 $1,109,117,871 7,886,780
2020-03-31 $926,752,095 7,067,430